| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.38▲ | 6.26▲ | 6.26▲ | 5.29▲ | 4.11▲ |
| MA10 | 6.32▲ | 6.22▲ | 6.18▲ | 4.29▲ | 3.93▲ |
| MA20 | 6.27▲ | 6.11▲ | 5.90▲ | 3.96▲ | 3.01▲ |
| MA50 | 6.17▲ | 5.17▲ | 4.54▲ | 3.82▲ | 3.09▲ |
| MA100 | 5.81▲ | 4.30▲ | 4.00▲ | 2.91▲ | 4.24▲ |
| MA200 | 4.84▲ | 4.07▲ | 4.04▲ | 2.74▲ | 55.98▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.016▲ | -0.042▼ | -0.031▼ | 0.325▲ | 0.292▲ |
| RSI | 66.733▲ | 72.470▲ | 77.670▲ | 77.124▲ | 67.031▲ |
| STOCH | 58.728 | 79.871 | 84.781▲ | 78.219 | 60.969 |
| WILL %R | -29.310 | -16.190▲ | -6.204▲ | -3.038▲ | -2.188▲ |
| CCI | 163.729▲ | 199.695▲ | 134.787▲ | 187.439▲ | 251.942▲ |
|
Friday, December 12, 2025 01:13 PM
CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to ...
|
|
Wednesday, December 10, 2025 03:26 AM
Key Insights Significantly high institutional ownership implies Camp4 Therapeutics' stock price is sensitive to ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/12/25 | 5.89 | 6.6025 | 5.63 | 6.49 | 242,207 |
| 11/12/25 | 5.42 | 6.28 | 4.89 | 6.01 | 217,400 |
| 10/12/25 | 4.56 | 5.95 | 4.41 | 5.72 | 376,900 |
| 09/12/25 | 3.53 | 4.691 | 3.43 | 4.60 | 211,800 |
| 08/12/25 | 3.37 | 3.806 | 3.37 | 3.65 | 165,100 |
| 05/12/25 | 3.45 | 3.60 | 3.231 | 3.25 | 67,500 |
| 04/12/25 | 3.34 | 3.44 | 3.14 | 3.39 | 52,700 |
| 03/12/25 | 3.41 | 3.48 | 3.16 | 3.25 | 56,646 |
| 02/12/25 | 3.28 | 3.52 | 3.23 | 3.31 | 48,500 |
| 01/12/25 | 3.66 | 3.6901 | 3.20 | 3.24 | 81,917 |
|
|
||||
|
|
||||
|
|